Lipid disorders in Chinese populations

Bibliography

• Farzadfar F, Finucane MM, Danaei G et al. National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 countryyears and 3.0 million participants. Lancet 377, 578–586 (2011)
   Google Scholar
• Yang G, Kong L, Zhao W et al. Emergence of chronic non-communicable diseases in China. Lancet 372, 1697–1705 (2008). n Describes the changing patterns of mortality in China
   Google Scholar
• Liu L. Cardiovascular diseases in China. Biochem. Cell. Biol. 85, 157–163 (2007)
   Google Scholar
• Zhang LF, Yang J, Hong Z et al. Proportion of different subtypes of stroke in China. Stroke 34, 2091–2096 (2003)
   Google Scholar
• Zheng Y, Stein R, Kwan T et al. Evolving cardiovascular disease prevalence, mortality, risk factors, and the metabolic syndrome in China. Clin. Cardiol. 32, 491–497 (2011)
   Google Scholar
• Gu D, Gupta A, Muntner P et al. Prevalence of cardiovascular disease risk factor clustering among the adult population of China: results from the International Collaborative Study of Cardiovascular Disease in Asia (InterAsia). Circulation 112, 658–665 (2005)
   Google Scholar
• He J, Gu D, Reynolds K et al. Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China. Circulation 110, 405–411 (2004). nn Large national study in China reporting the prevalence and treatment of hypercholesterolemia in China
   Google Scholar
• Wu Z, Yao C, Zhao D et al. Cardiovascular disease risk factor levels and their relations to CVD rates in China – results of Sino- MONICA project. Eur. J. Cardiovasc. Prev. Rehabil. 11, 275–283 (2004)
   Google Scholar
• Wu Z, Yao C, Zhao D et al. Sino-MONICA project: a collaborative study on trends and determinants in cardiovascular diseases in China, Part I: morbidity and mortality monitoring. Circulation 103, 462–468 (2001)
   Google Scholar
• Zhao WH, Zhang J, Zhai Y et al. Blood lipid profile and prevalence of dyslipidemia in Chinese adults. Biomed. Environ. Sci. 20, 329–335 (2007)
   Google Scholar
• Li Z, Yang R, Xu G, Xia T. Serum lipid concentrations and prevalence of dyslipidemia in a large professional population in Beijing. Clin. Chem. 51, 144–150 (2005)
   Google Scholar
• Li ZY, Xu GB, Xia TA. Prevalence rate of metabolic syndrome and dyslipidemia in a large professional population in Beijing. Atherosclerosis 184, 188–192 (2011)
   Google Scholar
• Liao Y, Liu Y, Mi J, Tang C, Du J. Risk factors for dyslipidemia in Chinese children. Acta Paediatr. 97, 1449–1453 (2008)
   Google Scholar
• Wu JY, Duan XY, Li L et al. Dyslipidemia in Shanghai, China. Prev. Med. 51, 412–415 (2010)
   Google Scholar
• Tomlinson B, Pang CC, Chan P. Hyperlipidaemia in Chinese populations. Hosp. Med. 59, 549–552 (1998). n A good early summary on lipid disorders in Chinese populations
   Google Scholar
• Pan WH, Chiang BN. Plasma lipid profiles and epidemiology of atherosclerotic diseases in Taiwan – a unique experience. Atherosclerosis 118, 285–295 (1995)
   Google Scholar
• Department of Health Annual Report 2011/2007. The Government of Hong Kong Special Administrative Region. Government Publications Centre, Hong Kong (2007)
   Google Scholar
• Pang RW, Tam S, Janus ED et al. Plasma lipid, lipoprotein and apolipoprotein levels in a random population sample of 2875 Hong Kong Chinese adults and their implications (NCEP ATP-III, 2001 guidelines) on cardiovascular risk assessment. Atherosclerosis 184, 438–445 (2011)
   Google Scholar
• Wu DM, Pai L, Chu NF et al. Prevalence and clustering of cardiovascular risk factors among healthy adults in a Chinese population: the MJ Health Screening Center Study in Taiwan. Int. J. Obes. Relat. Metab. Disord. 25, 1189–1195 (2001)
   Google Scholar
• Tai ES, Tan CE. Genes, diet and serum lipid concentrations: lessons from ethnically diverse populations and their relevance to coronary heart disease in Asia. Curr. Opin. Lipidol. 15, 5–12 (2004). n A good summary on gene-diet interactions on lipid levels
   Google Scholar
• Zhang J, Kesteloot H. Differences in all-cause, cardiovascular and cancer mortality between Hong Kong and Singapore: role of nutrition. Eur. J. Epidemiol. 17, 469–477 (2001)
   Google Scholar
• Dwyer T, Emmanuel SC, Janus ED, Wu Z, Hynes KL, Zhang C. The emergence of coronary heart disease in populations of Chinese descent. Atherosclerosis 167, 303–310 (2003). nn Analysis of coronary heart disease risk facors among Singapore, Hong Kong and mainland China that identied that serum total cholesterol was the only risk factor that was markedly higher in Singapore Chinese
   Google Scholar
• Lee J, Heng D, Chia KS, Chew SK, Tan BY, Hughes K. Risk factors and incident coronary heart disease in Chinese, Malay and Asian Indian males: the Singapore Cardiovascular Cohort Study. Int. J. Epidemiol. 30, 983–988 (2001)
   Google Scholar
• Li N, Tuomilehto J, Dowse G, Virtala E, Zimmet P. Prevalence of coronary heart disease indicated by electrocardiogram abnormalities and risk factors in developing countries. J. Clin. Epidemiol. 47, 599–611 (1994)
   Google Scholar
• Anand SS, Yusuf S, Vuksan V et al. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet 356, 279–284 (2000)
   Google Scholar
• Pinnelas D, De La Torre R, Pugh J, Strand C, Horowitz SF. Total serum cholesterol levels in Asians living in New York city: results of a self-referred cholesterol screening. NY State J. Med. 92, 245–249 (1992)
   Google Scholar
• Gerber L, Madhavan S. Epidemiology of coronary heart disease in migrant Chinese populations. Med. Anthropol. 4, 307–320 (1980)
   Google Scholar
• Garg A, Simha V. Update on dyslipidemia. J. Clin. Endocrinol. Metab. 92, 1581–1589 (2007)
   Google Scholar
• Sullivan D. Guidelines for the diagnosis and management of familial hypercholesterolaemia. Heart. Lung. Circ. 16, 25–27 (2007)
   Google Scholar
• Maruyama T, Miyake Y, Tajima S et al. Common mutations in the low-densitylipoprotein- receptor gene causing familial hypercholesterolemia in the Japanese population. Arterioscler. Thromb. Vasc. Biol. 15, 1713–1718 (1995)
   Google Scholar
• Sun XM, Patel DD, Webb JC et al. Familial hypercholesterolemia in China. Identification of mutations in the LDL-receptor gene that result in a receptor-negative phenotype. Arterioscler. Thromb 14, 85–94 (1994)
   Google Scholar
• Pimstone SN, Sun XM, du Souich C, Frohlich JJ, Hayden MR, Soutar AK. Phenotypic variation in heterozygous familial hypercholesterolemia: a comparison of Chinese patients with the same or similar mutations in the LDL receptor gene in China or Canada. Arterioscler. Thromb. Vasc. Biol. 18, 309–315 (1998)
   Google Scholar
• Alonso R, Mata N, Castillo S et al. Cardiovascular disease in familial hypercholesterolemia: influence of lowdensity lipoprotein receptor mutation type and classic risk factors. Atherosclerosis 200, 315–321 (2008)
   Google Scholar
• Bujo H, Takahashi K, Saito Y et al. Clinical features of familial hypercholesterolemia in Japan in a database from 1996–1998 by the research committee of the ministry of health, labour and welfare of Japan. J. Atheroscler. Thromb. 11, 146–151 (2004)
   Google Scholar
• Chiou KR, Charng MJ. Detection of mutations and large rearrangements of the low-density lipoprotein receptor gene in Taiwanese patients with familial hypercholesterolemia. Am. J. Cardiol. 105, 1752–1758 (2010)
   Google Scholar
• Syme SL, Marmot MG, Kagan A, Kato H, Rhoads G. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: introduction. Am. J. Epidemiol. 102, 477–480 (1975)
   Google Scholar
• Li N, Tuomilehto J, Dowse G et al. Electrocardiographic abnormalities and associated factors in Chinese living in Beijing and in Mauritius. The Mauritius Non- Communicable Disease Study Group. BMJ 304, 1596–1601 (1992)
   Google Scholar
• Leung SS, Lee WT, Lui SS et al. Fat intake in Hong Kong Chinese children. Am. J. Clin. Nutr. 72, 1373S–1378S (2000)
   Google Scholar
• Woo J, Leung SS, Ho SC, Lam TH, Janus ED. Dietary intake and practices in the Hong Kong Chinese population. J. Epidemiol. Community Health 52, 631–637 (1998)
   Google Scholar
• Lee MM, Pan WH, Yu SL, Huang PC. Foods predictive of nutrient intake in Chinese diet in Taiwan: I. Total calories, protein, fat and fatty acids. Int. J. Epidemiol. 21, 922–928 (1992)
   Google Scholar
• Xu WH, Ruan XN, Fu XJ et al. Prevalence of the metabolic syndrome in Pudong new area of Shanghai using three proposed definitions among Chinese adults. BMC Pub. Health 10, 246 (2010)
   Google Scholar
• Tomlinson B, Deng HB, Thomas GN. Prevalence of obesity amongst Chinese population revisited. Future Lipidol. 3, 139–152 (2008)
   Google Scholar
• Wang Y, Mi J, Shan XY, Wang QJ, Ge KY. Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China. Int. J. Obes. (Lond.) 31, 177–188 (2007). n Comprehensive investigation of the trends in obesity and obesity-related chronic disease in China
   Google Scholar
• Pollin TI, Hsueh WC, Steinle NI, Snitker S, Shuldiner AR, Mitchell BD. A genome-wide scan of serum lipid levels in the old order Amish. Atherosclerosis 173, 89–96 (2004)
   Google Scholar
• Lusis AJ, Pajukanta P. A treasure trove for lipoprotein biology. Nat. Genet. 40, 129–130 (2008)
   Google Scholar
• Willer CJ, Sanna S, Jackson AU et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat. Genet. 40, 161–169 (2008)
   Google Scholar
• Kathiresan S, Willer CJ, Peloso GM et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat. Genet. 41, 56–65 (2011)
   Google Scholar
• Kathiresan S, Melander O, Guiducci C et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat. Genet. 40, 189–197 (2008)
   Google Scholar
• Cutter J, Tan BY, Chew SK. Levels of cardiovascular disease risk factors in Singapore following a national intervention programme. Bull. World Health Organ. 79, 908–915 (2001)
   Google Scholar
• Teslovich TM, Musunuru K, Smith AV et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466, 707–713 (2010)
   Google Scholar
• Liu Y, Zhou D, Zhang Z et al. Effects of genetic variants on lipid parameters and dyslipidemia in a Chinese population. J. Lipid Res. 52, 354–360 (2011)
   Google Scholar
• Andreotti G, Menashe I, Chen J et al. Genetic determinants of serum lipid levels in Chinese subjects: a population-based study in Shanghai, China. Eur. J. Epidemiol. 24, 763–774 (2011)
   Google Scholar
• Bennet AM, Di Angelantonio E, Ye Z et al. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA 298, 1300–1311 (2007)
   Google Scholar
• Tan CE, Tai ES, Tan CS et al. APOE polymorphism and lipid profile in three ethnic groups in the Singapore population. Atherosclerosis 170, 253–260 (2003)
   Google Scholar
• Jofre-Monseny L, Minihane AM, Rimbach G. Impact of apoE genotype on oxidative stress, inflammation and disease risk. Mol. Nutr. Food Res. 52, 131–145 (2008)
   Google Scholar
• Liu ZK, Hu M, Baum L, Thomas GN, Tomlinson B. Associations of polymorphisms in the apolipoprotein A1/C3/A4/A5 gene cluster with familial combined hyperlipidaemia in Hong Kong Chinese. Atherosclerosis 208, 427–432 (2010)
   Google Scholar
• Sarwar N, Sandhu MS, Ricketts SL et al. Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. Lancet 375, 1634–1639 (2010)
   Google Scholar
• Pennacchio LA, Olivier M, Hubacek JA, Krauss RM, Rubin EM, Cohen JC. Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum. Mol. Genet. 11, 3031–3038 (2002)
   Google Scholar
• Hsu LA, Ko YL, Chang CJ et al. Genetic variations of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan. Atherosclerosis 185, 143–149 (2011)
   Google Scholar
• Ordovas JM, Robertson R, Cleirigh EN. Gene-gene and gene-environment interactions defining lipid-related traits. Curr. Opin. Lipidol. 22, 129–136 (2011)
   Google Scholar
• Tai ES, Ordovas JM, Corella D et al. The TaqIB and -629C>A polymorphisms at the cholesteryl ester transfer protein locus: associations with lipid levels in a multiethnic population. The 1998 Singapore National Health Survey. Clin. Genet. 63, 19–30 (2003)
   Google Scholar
• Tai ES, Corella D, Deurenberg-Yap M et al. Dietary fat interacts with the -514C>T polymorphism in the hepatic lipase gene promoter on plasma lipid profiles in a multiethnic Asian population: the 1998 Singapore National Health Survey. J. Nutr. 133, 3399–3408 (2003)
   Google Scholar
• Chan E, Tan CS, Deurenberg-Yap M, Chia KS, Chew SK, Tai ES. The V227A polymorphism at the PPARA locus is associated with serum lipid concentrations and modulates the association between dietary polyunsaturated fatty acid intake and serum high density lipoprotein concentrations in Chinese women. Atherosclerosis 187, 309–315 (2011)
   Google Scholar
• Sun JY, Zhao D, Wang W et al. [The changing trend of serum total cholesterol in Beijing population aged 25–64 years during 1984 - 1999]. Zhonghua Nei Ke Za Zhi 45, 980–984 (2011)
   Google Scholar
• Critchley J, Liu J, Zhao D, Wei W, Capewell S. Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999. Circulation 110, 1236–1244 (2004)
   Google Scholar
• Zhang X, Patel A, Horibe H et al. Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. Int. J. Epidemiol. 32, 563–572 (2003)
   Google Scholar
• Verschuren WM, Jacobs DR, Bloemberg BP et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. JAMA 274, 131–136 (1995)
   Google Scholar
• Navas-Nacher EL, Colangelo L, Beam C, Greenland P. Risk factors for coronary heart disease in men 18 to 39 years of age. Ann. Intern. Med. 134, 433–439 (2001)
   Google Scholar
• Teo KK, Liu L, Chow CK et al. Potentially modifiable risk factors associated with myocardial infarction in China: the INTERHEART China study. Heart 95, 1857–1864 (2011)
   Google Scholar
• Yusuf S, Hawken S, Ounpuu S et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet 364, 937–952 (2004)
   Google Scholar
• Karthikeyan G, Teo KK, Islam S et al. Lipid profile, plasma apolipoproteins, and risk of a first myocardial infarction among Asians: an analysis from the INTERHEART Study. J. Am. Coll. Cardiol. 53, 244–253 (2011)
   Google Scholar
• Wang W, Zhao D, Liu J et al. [Serum total cholesterol and 10-year cardiovascular risk in a Chinese cohort aged 35–64 years]. Zhonghua Xin Xue Guan Bing Za Zhi 34, 169–173 (2011)
   Google Scholar
• Zhang XH, Lu ZL, Liu L. Coronary heart disease in China. Heart 94, 1126–1131 (2008). nn Recent comprehensive review on coronary heart disease in China
   Google Scholar
• Ren J, Grundy SM, Liu J et al. Long-term coronary heart disease risk associated with very-low-density lipoprotein cholesterol in Chinese: the results of a 15-year Chinese Multi-Provincial Cohort Study (CMCS). Atherosclerosis 211, 327–332 (2010)
   Google Scholar
• Schatzkin A, Hoover RN, Taylor PR et al. Serum cholesterol and cancer in the NHANES I epidemiologic followup study. National Health and Nutrition Examination Survey. Lancet 2, 298–301 (1987)
   Google Scholar
• Mannes GA, Maier A, Thieme C, Wiebecke B, Paumgartner G. Relation between the frequency of colorectal adenoma and the serum cholesterol level. N. Engl. J. Med. 315, 1634–1638 (1986)
   Google Scholar
• Sun ZJ, Huang YH, Wu JS et al. The association of serum lipids with the histological pattern of rectosigmoid adenoma in Taiwanese adults. BMC Gastroenterol. 11, 54 (2011)
   Google Scholar
• Yang X, So W, Ko GT et al. Independent associations between low-density lipoprotein cholesterol and cancer among patients with Type 2 diabetes mellitus. CMAJ 179, 427–437 (2008)
   Google Scholar
• Swanson KM, Hohl RJ. Anti-cancer therapy: targeting the mevalonate pathway. Curr. Cancer Drug. Targets 6, 15–37 (2011)
   Google Scholar
• Karp I, Behlouli H, Lelorier J, Pilote L. Statins and cancer risk. Am. J. Med. 121, 302–309 (2008)
   Google Scholar
• Neil A, Cooper J, Betteridge J et al. Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study. Eur. Heart J. 29, 2625–2633 (2008)
   Google Scholar
• Kim HS, Wu Y, Lin SJ et al. Current status of cholesterol goal attainment after statin therapy among patients with hypercholesterolemia in Asian countries and region: the Return on Expenditure Achieved for Lipid Therapy in Asia (REALITY-Asia) study. Curr. Med. Res. Opin. 24, 1951–1963 (2008)
   Google Scholar
• Li X, Xu Y, Li J, Hu D. The gender differences in baseline characteristics and statin intervention among outpatients with coronary heart disease in China: the China Cholesterol Education Program. Clin. Cardiol. 32, 308–314 (2011)
   Google Scholar
• Lee KK, Lee VW, Chan WK et al. Cholesterol goal attainment in patients with coronary heart disease and elevated coronary risk: results of the Hong Kong Hospital Audit study. Value Health 11(Suppl. 1), S91–S98 (2008)
   Google Scholar
• Cheng CW, Woo KS, Chan JC, Tomlinson B, You JH. Association between adherence to statin therapy and lipid control in Hong Kong Chinese patients at high risk of coronary heart disease. Br. J. Clin. Pharmacol. 58, 528–535 (2004)
   Google Scholar
• Lee E, Ryan S, Birmingham B et al. Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment. Clin. Pharmacol. Ther. 78, 330–341 (2005)
   Google Scholar
• Birmingham BK, Azumaya CT, Wei C, Chen Y, Mosqueda-Garcia R: Increased exposure levels of rosuvastatin, atorvastatin and simvastatin in Chinese and Japanese subjects: a class effect? Clin. Pharmacol. Ther. 83, S15 (2008)
   Google Scholar
• Yang J, Li LJ, Wang K et al. Race differences: modeling the pharmacodynamics of rosuvastatin in Western and Asian hypercholesterolemia patients. Acta Pharmacol. Sin. 32, 116–125 (2011)
   Google Scholar
• Hu M, Lui SS, Mak VW et al. Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients. Pharmacogenet. Genomics 20, 634–637 (2010)
   Google Scholar
• Zhang W, Yu BN, He YJ et al. Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males. Clin. Chim. Acta 373, 99–103 (2011)
   Google Scholar
• Keskitalo JE, Zolk O, Fromm MF, Kurkinen KJ, Neuvonen PJ, Niemi M. ABCG2 polymorphism markedly affects the pharmacokinetics of atorvastatin and rosuvastatin. Clin. Pharmacol. Ther. 86, 197–203 (2011)
   Google Scholar
• Hu M, To KK, Mak VW, Tomlinson B. The ABCG2 transporter and its relations with the pharmacokinetics, drug interaction and lipid-lowering effects of statins. Expert Opin. Drug Metab. Toxicol. 7, 49–62 (2011)
   Google Scholar
• Li JJ, Lu ZL, Kou WR et al. Impact of Xuezhikang on coronary events in hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS). Ann. Med. 42, 231–240 (2010)
   Google Scholar
• Becker DJ, Gordon RY, Halbert SC, French B, Morris PB, Rader DJ. Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial. Ann. Intern. Med. 150, 830–839, W147–W839 (2011)
   Google Scholar
• Li Z, Seeram NP, Lee R et al. Plasma clearance of lovastatin versus chinese red yeast rice in healthy volunteers. J. Altern. Complement. Med. 11, 1031–1038 (2005)
   Google Scholar
• Tachjian A, Maria V, Jahangir A. Use of herbal products and potential interactions in patients with cardiovascular diseases. J. Am. Coll. Cardiol. 55, 515–525 (2010)
   Google Scholar
• Yu S, Zhong B, Zheng M, Xiao F, Dong Z, Zhang H. The quality of randomized controlled trials on DanShen in the treatment of ischemic vascular disease. J. Altern. Complement. Med. 15, 557–565 (2011)
   Google Scholar
• Cheng J, Zhao D, Zeng Z et al. The impact of demographic and risk factor changes on coronary heart disease deaths in Beijing, 1999–2010. BMC Public Health 9, 30 (2011)
   Google Scholar
• Eliasson M, Janlert U, Jansson JH, Stegmayr B. Time trends in population cholesterol levels 1986–2004: influence of lipid-lowering drugs, obesity, smoking and educational level. The northern Sweden MONICA study. J. Intern. Med. 260, 551–559 (2011)
   Google Scholar
• Arnett DK, Jacobs DR Jr, Luepker RV, Blackburn H, Armstrong C, Claas SA. Twenty-year trends in serum cholesterol, hypercholesterolemia, and cholesterol medication use: the Minnesota Heart Survey, 1980–1982 to 2000–2002. Circulation 112, 3884–3891 (2005)
   Google Scholar
• Phua KH, Chew AH. Towards a comparative analysis of health systems reforms in the Asia–Pacific Region. Asia Pac. J. Public Health 14, 9–16 (2002)
   Google Scholar
• Li L. The challenges of healthcare reforms in China. Public Health 125, 6–8 (2011).
   Google Scholar